Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

1.260 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million.... 
Via Benzinga
News headline image
Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors
- Represents Sonnet's first IND cleared - Phase 1 trial initiation expected in 2Q22 PRINCETON, NJ / ACCESSWIRE / March 16, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
News headline image
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting
PRINCETON, NJ / ACCESSWIRE / February 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
News headline image
68 Biggest Movers From Yesterday ↗
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59... 
Via Benzinga
News headline image
Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update
- SON-1010 and SON-080 on track to initiate clinical studies during the second quarter of 2022 - Completed R&D manufacturing for SON-1210 non-GLP toxicity study in non-human primates, with study... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22.... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Syros Pharmaceuticals (NASDAQ:SYRS 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Indaptus Therapeutics (NASDAQ:INDP 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX 
Via Benzinga
News headline image
15 Stocks Moving in Monday's Pre-Market Session ↗
15 stocks that should be interesting to investors. 
Via Talk Markets
News headline image
15 Stocks Moving in Monday's Pre-Market Session ↗
Gainers IceCure Medical Ltd (NASDAQ: ICCM) rose 36.5% to $3.89 in pre-market trading. IceCure Medical, last week, received notice of intention to grant a European patent covering... 
Via Benzinga
News headline image
25 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index. Verso Corporation (NYSE:... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... 
Via Benzinga
News headline image
Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update
PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic... 
From Sonnet BioTherapeutics, Inc.
Via AccessWire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Applied DNA Sciences (NASDAQ:APDN... 
Via Benzinga
News headline image
21 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021 ↗
Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE: 
Via Benzinga
News headline image
18 Stocks Moving in Monday's Pre-Market Session ↗
Gainers CohBar, Inc. (NASDAQ: CWBR) rose 22.8% to $1.13 in pre-market trading after dropping over 4% on Friday. Farmmi, Inc.. (NASDAQ: FAMI) rose 13% to $0.3995 in pre-market... 
Via Benzinga
News headline image
53 Biggest Movers From Yesterday ↗
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation... 
Via Benzinga
Topics Initial Public Offering
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares... 
Via Benzinga
News headline image
38 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of... 
Via Benzinga
Topics Intellectual Property
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021 ↗
Upgrades For Alcoa Corp (NYSE: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
News headline image
26 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 46.1% to $0.6699 in pre-market trading after dropping 11% on Tuesday. MeaTech 3D Ltd. (NASDAQ: MITC) rose 18.5% to $6.29 in pre-market... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers GBS (NASDAQ:GBS) stock moved upwards by 51.23% to $4.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $60.6 million... 
Via Benzinga
News headline image
55 Biggest Movers From Yesterday ↗
Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Spok Holdings Surges On Takeover Offer; Sequential Brands Shares Slide ↗
Toward the end of trading Tuesday, the Dow traded down 0.09% to 35,366.93 while the NASDAQ fell 0.02% to 15,263.43. The S&P also fell, dropping 0.11% to 4,523.94. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Mid-Day Market Update: Zoom Shares Drop After Q2 Results; AC Immune Shares Surge ↗
Midway through trading Tuesday, the Dow traded down 0.01% to 35,396.15 while the NASDAQ fell 0.25% to 15,227.25. The S&P also fell, dropping 0.09% to 4,524.67. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
33 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.